Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Pharmacyclics, Inc. (NQ: PCYC)
84.89 USD  +0.97 (+1.16%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 17, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about Pharmacyclics, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
With 'Cell Death' Drugs, Bristol-Myers May Win No Matter What
May 15, 2013
A new class of anti-cancer drugs that allow the immune system to attack cancer cells are generating considerable excitement among patients, doctors, and investors. New results being released ahead of... Read More
category NYSE:JNJ , NYSE:MRK , NASDAQ:PCYC , and 2 more.
from Forbes Real Time
Benzinga's Top Upgrades
May 13, 2013
Analysts at McNicoll Lewis Vlak upgraded Digital Realty Trust (NYSE: DLR ) from “hold” to “buy.” The target price for Digital Realty Trust has been raised from $67.00 to $77.00. Digital Realty Trust's... Read More
category ORBK , DLR , Benzinga , and 5 more.
from Latest Articles from Benzinga.com
RBC Capital Upgrades Pharmacyclics (PCYC) to Outperform
May 13, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8329548 for the full story. Read More
from StreetInsider.com News Articles
Short Interest in Vertex Rises, in Celgene Falls
May 11, 2013
The short interest moves in biotech and emerging pharmaceutical companies were mixed in the latter two weeks of April. The number of shares sold short in Dendreon (NASDAQ: DNDN ), Gilead Sciences... Read More
category Regeneron Pharmaceuticals , amgen , Benzinga , and 35 more.
from Latest Articles from Benzinga.com
Six Superstars for Your Biotech Portfolio: John McCamant
May 10, 2013
category Pharmaceuticals
from Trefis
Six Superstars for Your Biotech Portfolio: John McCamant
May 09, 2013
Six Superstars for Your Biotech Portfolio: John McCamant Source: Tracy Salcedo-Chourr? of The Life Sciences Report (5/9/13) http://www.thelifesciencesreport.com/pub/na/15256 We are in the “golden age,”... Read More
category AZN , JNJ , ALKS , and 8 more.
from Bio-Wire.Com
Bull’s Eye Report: Amgen (AMGN)
May 09, 2013
 Read More
category NASDAQ:PCYC , NYSE:CVD , NASDAQ:AMGN
from InvestorPlace - Latest Headlines
Bull’s Eye Report: Pharmacyclics (PCYC)
May 07, 2013
 Read More
category NASDAQ:PCYC , NASDAQ:MDVN , NYSEARCA:XBI , and 2 more.
from InvestorPlace - Latest Headlines
Goldman Sachs Starts Pharmacyclics (PCYC) at Neutral
May 07, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8310680 for the full story. Read More
from StreetInsider.com News Articles
Three Top Performing Healthcare Stocks to Watch
May 06, 2013
The healthcare sector has been a very strong performer in 2013, driven in part by a near 12 percent rise in the S&P 500. The iShares Dow Jones US Healthcare ETF (NYSE: IYH ) had climbed better than 19... Read More
category SGEN , OPK , Benzinga , and 13 more.
from Latest Articles from Benzinga.com
Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential
May 03, 2013
category Pharmaceuticals , Industrials
from Trefis
Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential
May 02, 2013
Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential Source: George S. Mack of The Life Sciences Report (5/2/13) http://www.thelifesciencesreport.com/pub/na/15211 In January 2013, The... Read More
category GALE , NVS , ONXX , and 17 more.
from Bio-Wire.Com
Pharmacyclics Reports First Quarter 2013 Results
May 01, 2013
from PR Newswire
Short Sellers Move into Celgene, Regeneron
April 26, 2013
The short interest moves in biotech and emerging pharmaceutical companies were mixed in the first two weeks of April. The number of shares sold short in Alexion Pharmaceuticals (NASDAQ: ALXN ), Amgen... Read More
category Regeneron Pharmaceuticals , amgen , Benzinga , and 34 more.
from Latest Articles from Benzinga.com
Bull’s Eye Report: Polycyclics (PCYC)
April 26, 2013
 Read More
category NASDAQ:PCYC , NASDAQ:MDVN , NYSEARCA:XBI , and 2 more.
from InvestorPlace - Latest Headlines
Pharmacyclics Announces Date of Financial Results for Three Months Ended March 31, 2013 and Conference Call
April 24, 2013
from PR Newswire
Pharmacyclics Larger Than S&P 500 Component Interpublic Group of Companies
April 23, 2013
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Pharmacyclics, Inc. (PCYC) was identified as having a larger market cap than the smaller end of the S&P... Read More
category Stocks
from Market News Video
Stocks To Watch For April 23, 2013
April 22, 2013
( click to enlarge ) Pharmacyclics, Inc. (NASDAQ:PCYC) had a nice breakout today with a pop of $4.17 to 81.69 or 5.38% on 959K shares, the biggest volume in a couple weeks. The heavy buying makes this... Read More
category BBRY , SVU , TSLA , and 6 more.
from DailyMarkets.com
Stocks to Watch for April 23, 2013
April 22, 2013
category BBRY , SVU , TSLA , and 3 more.
from AC Investor Blog
Free Research Reports on CE, PCYC, RTK and TLAB Issued by the Paragon Report
April 22, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit Read More
from Marketwired News Releases
(PCYC) Pharmacyclics Earns 4th Milestone
April 21, 2013
Pharmacyclics, Inc. (PCYC) recently announced the enrollment of the fifth patient in a phase III... Visit StockBlogHub to view complete post. Read More
category JNJ , Pharmacyclics Inc , QLTI , and 7 more.
from Stock Blog Hub
9 Technical Setups for the Week Ahead
April 20, 2013
category KERX , IDCC , BBRY , and 6 more.
from AC Investor Blog
Pharmacyclics Completes Enrollment of First Phase III Ibrutinib CLL Study - RESONATE™ and Announces Completion of Enrollment of Phase II Ibrutinib MCL Study - SPARK
April 18, 2013
from PR Newswire
Amarin, Pharmacyclics, Anthera Pharma, Star Scientific, and Impax Laboratories Under StockCall's Microscope
April 16, 2013
from PR Newswire
Lower Prices Ahead
April 16, 2013
 Read More
category NASDAQ:PCYC , NASDAQ:AXLL , NYSEARCA:IWM , and 2 more.
from InvestorPlace - Latest Headlines
Pharmacyclics (PCYC) Hits $50M Milestone with RESONATE-2 Enrollment
April 11, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8246730 for the full story. Read More
from StreetInsider.com News Articles
Pharmacyclics Triggers Fourth Milestone Payment for Enrollment of 5th Patient in Frontline Phase III CLL Study
April 11, 2013
from PR Newswire
Short Sellers Move Out of Amgen, Celgene, Pharmacyclics
April 10, 2013
The short interest in biotech and emerging pharmaceutical companies was mixed in the final two weeks of March. The number of shares sold short in Alexion Pharmaceuticals (NASDAQ: ALXN ), Arena... Read More
category Regeneron Pharmaceuticals , amgen , Benzinga , and 32 more.
from Latest Articles from Benzinga.com
Free Research Reports on ANAC, GE, OMPI and PCYC Issued by the Paragon Report
April 09, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit Read More
from Marketwired News Releases
Pharmacyclics (PCYC) Updates on CLL Treatment Ibrutinib Phase II
April 08, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8238971 for the full story. Read More
from StreetInsider.com News Articles
< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here